
Kejal Pharmaceuticals LLP
About Kejal Pharmaceuticals LLP
Data last updated:
Kejal Pharmaceuticals LLP is a limited liability partnership (LLP) based in Navi Mumbai, Maharashtra, India. It operates in the retail trade segment of the home appliances and consumer durables sector. It was incorporated on 17 June 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAP-6494. Its GSTIN is 27AAVFK1050F1ZB (Maharashtra).
The LLP has a total obligation of contribution of ₹5 Lakh. It is led by designated partners Rajesh Lalitkumar Shah and Bhavana Kiran Kothari.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Flat 33/A Pl 63 Sector 17 Kaveri Vashi, Navi Mumbai, Maharashtra, India – 400703.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat 33/A Pl 63 Sector 17 Kaveri Vashi, Navi Mumbai, Maharashtra, India – 400703
- IndustryHome Appliances, Retailers, Repair Of Personal And Household Goods
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Kejal Pharmaceuticals LLP
Kejal Pharmaceuticals has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Lalitkumar Shah | Designated Partner | 17 Jun 2019 | 7 Years 3 Months | Current |
| Bhavana Kiran Kothari | Designated Partner | 18 Dec 2025 | 0 Years 9 Months | Current |
Financials of Kejal Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Kejal Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kejal Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Kejal Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kejal Pharmaceuticals LLP
Kejal Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Kejal Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Kejal Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Kejal Pharmaceuticals LLP
Kejal Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAVFK1050F1ZB | Maharashtra | Active | 27 Sep 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Kejal Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kejal Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kejal Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kejal Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Kejal Pharmaceuticals LLP
Frequently Asked Questions about Kejal Pharmaceuticals LLP
Kejal Pharmaceuticals is an active limited liability partnership based in Navi Mumbai, Maharashtra, India. The LLP works in retailers, within the home appliances industry. It was incorporated on 17 June 2019 (7+ years old) and is registered under LLPIN AAP-6494.
Kejal Pharmaceuticals has 2 current designated partners:
- Rajesh Lalitkumar Shah - Designated Partner
- Bhavana Kiran Kothari - Designated Partner
The GSTIN of Kejal Pharmaceuticals is 27AAVFK1050F1ZB, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Kejal Pharmaceuticals is AAP-6494. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Kejal Pharmaceuticals was incorporated on 17 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The registered office of Kejal Pharmaceuticals is at Flat 33A Pl 63 Sector 17 Kaveri Vashi, Navi Mumbai, Maharashtra, India – 400703.
The total obligation of contribution is ₹5 Lakh.
Kejal Pharmaceuticals operates in the home appliances industry, in the retailers segment.
Kejal Pharmaceuticals can be reached at its registered office: Flat 33A Pl 63 Sector 17 Kaveri Vashi, Navi Mumbai, Maharashtra, India – 400703.